All Stories

  1. High Recurrence Rates of Osteoid Osteoma Treated With Open Surgery and Radiofrequency Ablation
  2. Reassessing the 8 cm Cutoff: Continuous Tumor Size‐Mortality Risk Supports Three‐Tier Staging in High Grade Osteosarcoma
  3. Distance Weighted Matching in the Quantification of Excess Morbidity in External Hemipelvectomy and Hip Disarticulation
  4. Reverse total shoulder arthroplasty demonstrates improved functional outcomes and equivocal mid-term survival compared to hemiarthroplasty following oncologic reconstruction in proximal humerus replacement
  5. Intraoperative Navigation, 3D Printed Prostheses, and Conventional Techniques in Femoral and Tibial Tumor Resections: A Systematic Review
  6. Recurrence in Patients With Chondroblastoma Is Not Associated With Use of Surgical Adjuvants: A Single Center Retrospective Review
  7. Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group
  8. Single-Institution Experience With Nononcologic Total Femoral Replacement
  9. Cemented Constrained Liners Used as an Articulating Hip Spacer for the Treatment of Chronic Prosthetic Joint Infection
  10. Postoperative outcomes and trends in computer-navigated and robotic-assisted total hip arthroplasty
  11. An Updated Estimate of Total Hip and Total Knee Arthroplasty Inpatient Case Volume During the 2020 COVID-19 Pandemic in the United States
  12. Risk Factors for Peripheral Nerve Injury Following Revision Total Knee Arthroplasty in 132,960 Patients
  13. Risk Factors for Peripheral Nerve Injury Following Revision Total Hip Arthroplasty in 112,310 Patients
  14. Intravenous tranexamic acid reduces complications following surgical treatment of pathologic fractures of the lower extremity
  15. Characteristics of Very Young Patients Undergoing Total Hip Arthroplasty: A Contemporary Assessment
  16. Tandem Reconstruction of the Femoral Diaphysis Using an Intercalary Prosthesis and a Fibular Free Flap
  17. Postoperative Complications Associated with Non-Steroidal Anti-Inflammatory Combinations Used Status-Post Total Hip and Knee Arthroplasty
  18. Medicare Advantage in Soft Tissue Sarcoma May Be Associated with Worse Patient Outcomes
  19. Increased Risk of Venous Thromboembolism in Patients with Postoperative Anemia After Total Joint Arthroplasty
  20. Complications and Safety of Simultaneous Bilateral Total Knee Arthroplasty
  21. Cemented versus Cementless Femoral Fixation for Elective Primary Total Hip Arthroplasty: A Nationwide Analysis of Short-Term Complication and Readmission Rates
  22. Prevalence of primary malignant tumours, rates of pathological fracture, and mortality in the setting of metastatic bone disease
  23. Tumors Constitute a Majority of Total Knee Arthroplasty in Patients <21 Years Old: A United States Nationwide Analysis
  24. Supplementary Methods and Figures S1 to S7 from CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
  25. Supplementary Methods and Figures S1 to S7 from CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
  26. Data from CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
  27. Data from CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
  28. Duloxetine for Postoperative Pain Control Following Knee or Hip Replacement: A Systematic Review and Meta-Analysis
  29. Peripheral Nerve Block Utilization is Associated With Decreased Postoperative Opioid Consumption and Shorter Length of Stay Following Total Knee Arthroplasty
  30. Postoperative Complication and Reoperation Rates Following Resection of Soft Tissue vs. Bone Malignancies Based on Anatomic Location in the Inpatient Setting
  31. Functional outcomes of oncologic reverse total shoulder arthroplasty after tumor resection
  32. Computer-Navigated and Robotic-Assisted Total Knee Arthroplasty: Increasing in Popularity Without Increasing Complications
  33. The Rise of Medicare Advantage
  34. Operative management of metastatic disease of the acetabulum: review of the literature and prevailing concepts
  35. Timing of treatment in osteosarcoma: challenges and perspectives – a scoping review
  36. Modern Proximal Femoral Replacement in Revision Total Hip Arthroplasty for Nononcologic Indications
  37. Tumor lysis syndrome following ifosfamide monotherapy in metastatic osteosarcoma: a case report and review of the literature
  38. Midterm Survivorship of Robotic-Assisted Lateral Unicompartmental Knee Arthroplasty
  39. Elective Inpatient Total Joint Arthroplasty Case Volume in the United States in 2020
  40. Industry Payment Trends to Orthopaedic Surgeons From 2014 to 2018: An Analysis of the First 5 Years of the Open Payments Database
  41. Periacetabular reconstruction following limb-salvage surgery for pelvic sarcomas
  42. Cemented Vs Cementless Femoral Fixation for Total Hip Arthroplasty After Displaced Femoral Neck Fracture: A Nationwide Analysis of Short-Term Complications and Readmission Rates
  43. Patient Perception Regarding the Safety of Elective Joint Arthroplasty Surgery During the COVID-19 Pandemic
  44. Limb Length Discrepancy in Total Hip Arthroplasty: Is the Lesser Trochanter a Reliable Measure of Leg Length?
  45. The critical difference in the DASH (Disabilities of the Arm, Shoulder, and Hand) outcome measure after essential upper extremity tumor surgery
  46. Distal femoral replacement – Cemented or cementless? Current concepts and review of the literature
  47. Computer-Assisted Surgical Navigation for Primary and Metastatic Bone Malignancy of the Pelvis: Current Evidence and Future Directions
  48. Periprosthetic Femur Fractures After Total Hip Arthroplasty: Does the Mode of Failure Correlate With Classification?
  49. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
  50. Dose-Dependent Early Postoperative Opioid Use Is Associated with Periprosthetic Joint Infection and Other Complications in Primary TJA
  51. Postradiation Fractures after Combined Modality Treatment in Extremity Soft Tissue Sarcomas
  52. Compliant Compression Reconstruction of the Proximal Femur Is Durable Despite Minimal Bone Formation in the Compression Segment
  53. Interlocking reconstruction-mode stem-sideplates preserve at-risk hips with short residual proximal femora
  54. Response to Letter to the Editor on “Prospective Evaluation of the Posterior Tissue Envelope and Anterior Capsule After Anterior Total Hip Arthroplasty”
  55. What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?
  56. Letter to the Editor on “A Meta-Analysis of Outcomes in Total Hip Arthroplasty Recipients Following Pelvic Irradiation”
  57. Prospective Evaluation of the Posterior Tissue Envelope and Anterior Capsule After Anterior Total Hip Arthroplasty
  58. Risk Factors for Peripheral Nerve Injury After 207,000 Total Hip Arthroplasties Using a New York State Database (Statewide Planning and Research Cooperative System)
  59. Outcomes and complications following non-oncologic total femoral replacement
  60. Osteointegration in Compliant Self-Adjusting Compression Fixation Shown by Backscatter Electron Microscopy: A Case Report
  61. Incidence and Risk Factors for Peripheral Nerve Injury after 383,000 Total Knee Arthroplasties Using a New York State Database (SPARCS)
  62. Return to the operating room after patellofemoral arthroplasty versus total knee arthroplasty for isolated patellofemoral arthritis—a systematic review
  63. Radiographic and Clinical Outcomes of Periprosthetic Distal Femur Fractures Treated With Open Reduction Internal Fixation
  64. Advances in Patellofemoral Arthroplasty
  65. Robotic-Assisted Unicompartmental Knee Arthroplasty: State-of-the Art and Review of the Literature
  66. Neutral mechanical alignment: Stickin’ with the one that brung ya- Affirms
  67. Discharge to Inpatient Rehab Does Not Result in Improved Functional Outcomes Following Primary Total Knee Arthroplasty.
  68. Nerve Traction Injury After Subacute Revision External Fixation of a Tibial Plateau Fracture
  69. Support for Safer Opioid Prescribing Practices
  70. Patellofemoral arthroplasty conversion to total knee arthroplasty: Retrieval analysis and clinical correlation
  71. HPMA–Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer
  72. Tracking Cumulative Radiation Exposure in Orthopaedic Surgeons and Residents
  73. Total Knee Arthroplasty for Knee Osteoarthritis: Support for a Foregone Conclusion?
  74. Annual revision rates of partial versus total knee arthroplasty: A comparative meta-analysis
  75. Rotator Cuff-Sparing Approach for Antegrade Humeral Nailing With Biceps Tenodesis
  76. Mycobacterium avium Complex Septic Arthritis Presenting as Osteonecrosis of the Femoral Head in a Patient With Systemic Lupus Erythematosus
  77. The triceps-sparing posterior approach to plating humeral shaft fractures results in a high rate of union and low incidence of complications
  78. Direct Repair of the Superior Band of Bigelow’s Ligament After Hip Arthroplasty: a Surgical Technique
  79. Bilateral Complete Osseous Coalition of the Capitate and Trapezoid
  80. Neuropilin-2 expression is inhibited by secreted Wnt antagonists and its down-regulation is associated with reduced tumor growth and metastasis in osteosarcoma
  81. Hip Reconstruction
  82. Combined Flexor-Pronator Mass and Ulnar Collateral Ligament Injuries
  83. Online Resources for Shoulder Instability: What Are Patients Reading?
  84. The Increased Total Cost Associated With Post-Operative Drains in Total Hip and Knee Arthroplasty
  85. Periprosthetic Joint Infections Treated with Two-Stage Revision over 14Years: An Evolving Microbiology Profile
  86. Dkk-3, a Secreted Wnt Antagonist, Suppresses Tumorigenic Potential and Pulmonary Metastasis in Osteosarcoma
  87. Abstract 236: DKK-3, a secreted Wnt antagonist, suppresses tumorigenic potential and lung metastasis of osteosarcoma
  88. Abstract 2348: Frzb/sFRP3 inhibits lung metastasis of osteosarcoma
  89. Abstract 3963: Wnt-Signaling regulates angiogenesis by regulating Neuropilin-1 expression in osteosarcoma
  90. Flexibility in the site of exon junction complex deposition revealed by functional group and RNA secondary structure alterations in the splicing substrate